RecruitingNot ApplicableNCT04929821

UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures


Sponsor

QualiMed Innovative Medizinprodukte GmbH

Enrollment

100 participants

Start Date

Oct 16, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

STUDY TYPE: Feasibility study STUDY DESIGN: Prospective, multicenter, single-arm, open-label PRIMARY OBJECTIVE The primary objective is to assess safety of the UNITY Balloon-expandable Biodegradable Biliary Stent System SECONDARY OBJECTIVES Clinical /Technical /Procedural success, Quality of Life improvement, biodegradation rate


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Biliary Duct Stenting for people with bile duct diseases, bile duct stricture, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBiliary Duct Stenting

UNITY-B Balloon-expandable Biodegradable Biliary Stent deployment in obstructed biliary ducts.


Locations(6)

Queen Mary Hospital

Hong Kong, Hong Kong

The Prince of Wales Hospital

Hong Kong, Hong Kong

AIG Hospitals (Asian Institute of Gastroenterology)

Hyderabad, India

Sunway Medical Centre

Kuala Lumpur, Malaysia

Universityi Kebangsaan Malaysia (UKM)

Kuala Lumpur, Malaysia

University Malaya Medical Centre (UMMC)Clinical Investigation Centre (CIC)

Kuala Lumpur, Malaysia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04929821


Related Trials